Connecting the early brain injury of aneurysmal subarachnoid hemorrhage to clinical practice;Anevrizmal subaraknoid kanamada erken beyin hasarinin klinik pratik ile i̇lişkilendirilmesi

Turkish Neurosurgery

Volumn 20, Issue 2, 2010, Pages 159-166

  Ayer, Robert ^a   Zhang, John ^b  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Early brain injury; Edema; Infarction; Inflammation; Oxidative stress; Subarachnoid hemorrhage

Indexed keywords

APOPTOSIS; BRAIN CIRCULATION; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INJURY; BRAIN VASOSPASM; ENCEPHALITIS; HUMAN; INTRACRANIAL HYPERTENSION; MORTALITY; OXIDATIVE STRESS; PATHOLOGY; SUBARACHNOID HEMORRHAGE;

APOPTOSIS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; ENCEPHALITIS; HUMANS; INTRACRANIAL HYPERTENSION; OXIDATIVE STRESS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 77953854872     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Arai T, Takeyama N, Tanaka T. Glutathione monoethyl ester and inhibition of the oxyhemoglobin-induced increase in cytosolic calcium in cultured smooth-muscle cells. J Neurosurg 90. 527-532, 1999.
2. Asano T. Oxyhemoglobin as the principal cause of cerebral vasospasm. A holistic view of its actions. Crit Rev Neurosurg 9. 303-318, 1999.
3. Ayer RE, Sugawara T, Chen W, Tong W, Zhang JH: Melatonin decreases mortality following severe subarachnoid hemorrhage. J Pineal Res 44. 197-204, 2008.
4. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab 25. 1634-1644, 2005.
5. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94. 10873-10878, 1997.
6. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25. 1342-1347, 1994.
7. Busch E, Beaulieu C, de CA, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke 29. 2155-2161, 1998.
8. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26. 1341-1353, 2006.
9. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage. frequency, predictors, and impact on outcome. Stroke 33. 1225-1232, 2002.
10. Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, Fitzsimmons BF, Connolly ES, Mayer SA. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 32. 832-838, 2004.
11. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 66. 259-284, 1995.
12. Ellington E, Margolis G. Block of arachnoid villus by subarachnoid hemorrhage. J Neurosurg 30. 651-657, 1969.
13. Endo H, Nito C, Kamada H, Yu F, Chan PH. Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3beta survival signaling. J Cereb Blood Flow Metab 27. 975-982, 2007.
14. Feigin VL, Anderson N, Rinkel GJ, Algra A, van GJ, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 3; CD004583, 2005.
15. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology. a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2. 43-53, 2003.
16. Figueroa S, Oset-Gasque MJ, Arce C, Martinez-Honduvilla CJ, Gonzalez MP. Mitochondrial involvement in nitric oxideinduced cellular death in cortical neurons in culture. J Neurosci Res 83: 441-449, 2006.
17. Foltz EL, Ward AA, Jr. Communicating hydrocephalus from subarachnoid bleeding. J Neurosurg 13. 546-566, 1956.
18. Gaetani P, Lombardi D. Brain damage following subarachnoid hemorrhage. the imbalance between antioxidant systems and lipid peroxidative processes: J Neurosurg Sci 36.1-10, 1992.
19. Gaetani P, Pasqualin A, Baena R, Borasio E, Marzatico F. Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 89. 748-754, 1998.
20. Gee JM, Kalil A, Shea C, Becker KJ. Lymphocytes. Potential mediators of postischemic injury and neuroprotection. Stroke 38. 783-788, 2007.
21. Germano A, Imperatore C, d'Avella D, Costa G, Tomasello F. Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage. J Neurosurg 88: 1075-1081, 1998.
22. Goldman DW, Breyer RJ, III Yeh D, Brockner-Ryan BA, Alayash AI. Acellular hemoglobin-mediated oxidative stress toward endothelium. A role for ferryl iron. Am J Physiol 275: H1046-H1053, 1998.
23. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery 22. 654-661, 1988.
24. Grubb RL, Jr Raichle ME, Eichling JO, Gado MH. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans. J Neurosurg 46. 446-453, 1977.
25. Haley EC, Jr Kassell N.F, Pperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. a cooperative study in North America. J Neurosurg 86. 467-474, 1997.
26. Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol 184. 100-112, 2007.
27. Heuer GG, Smith MJ, Elliott JP, Winn HR, LeRoux PD. Relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 101. 408-416, 2004.
28. Hop JW, Rinkel GJ, Algra A, van GJ. Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 28. 660-664, 1997.
29. Horstmann S, Su Y, Koziol J, Meyding-Lamade U, Nagel S, Wagner S. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci 251. 82-86, 2006.
30. Hutter BO, Kreitschmann-Andermahr I, Mayfrank L, Rohde V, Spetzger U, Gilsbach JM: Functional outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 72.157-174, 1999.
31. Imperatore C, Germano A, d'Avella D, Tomasello F, Costa G. Effects of the radical scavenger AVS on behavioral and BBB changes after experimental subarachnoid hemorrhage. Life Sci 66. 779-790, 2000.
32. Kamiya K, Kuyama H, Symon L. An experimental study of the acute stage of subarachnoid hemorrhage. J Neurosurg 59. 917-924, 1983.
33. Kassell NF, Haley EC, Jr Pperson-Hansen C, Alves WM. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84. 221-228, 1996.
34. Kassell NF, Torner JC, Haley EC, Jr Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1. Overall management results. J Neurosurg 73. 18-36, 1990.
35. Kaynar MY, Tanriverdi T, Kemerdere R, Atukeren P, Gumustas K. Cerebrospinal fluid superoxide dismutase and serum malondialdehyde levels in patients with aneurysmal subarachnoid hemorrhage. Preliminary results. Neurol Res 27. 562-567, 2005.
36. Keep RF, Andjelkovic AV, Stamatovic SM, Shakui P, Ennis SR. Ischemia-induced endothelial cell dysfunction. Acta Neurochir Suppl 95. 399-402, 2005.
37. Kim I, Leinweber BD, Morgalla M, Butler WE, Seto M, Sasaki Y, Peterson JW, Morgan KG. Thin and thick filament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 46. 440-446, 2000.
38. Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, Du YE, Stern Y, Connolly ES, Mayer SA. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 33. 200-208, 2002.
39. Kubota T, Handa Y, Tsuchida A, Kaneko M, Kobayashi H, Kubota T. The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke 24. 1993-2000, 1993.
40. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 24. 916-925, 2004.
41. Lagares A, Gomez PA, Lobato RD, Alen JF, Alday R, Campollo J. Prognostic factors on hospital admission after spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien.) 143. 665-672, 2001.
42. Langfitt TW, Weinstein JD, Kassell NF, Gagliardi LJ. Transmission of increased intracranial pressure. II. Within the supratentorial space. J Neurosurg 21. 998-1005, 1964.
43. Langfitt TW, Weinstein JD, Kassell NF, Simeone FA. Transmission of increased intracranial pressure. I. Within the craniospinal axis. J Neurosurg 21. 989-997, 1964.
44. Lanzino G, Kassell NF. Double-blind, randomized, vehiclecontrolled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90. 1018-1024, 1999.
45. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90. 1011-1017, 1999.
46. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 17. 871-890, 2000.
47. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1). randomized, double-blind, placebocontrolled phase 2 dose-finding trial. Stroke 39. 3015-3021, 2008.
48. Macdonald RL, Weir B, Zhang J, Marton LS, Sajdak M, Johns LM. Adenosine triphosphate and hemoglobin in vasospastic monkeys. Neurosurg Focus 3. e3, 1997.
49. Mandal M, Mandal A, Das S, Chakraborti T, Sajal C. Clinical implications of matrix metalloproteinases. Mol Cell Biochem 252. 305-329, 2003.
50. Marzatico F, Gaetani P, Cafe C, Spanu G, Baena R. Antioxidant enzymatic activities after experimental subarachnoid hemorrhage in rats. Acta Neurol Scand 87. 62-66, 1993.
51. Marzatico F, Gaetani P, Tartara F, Bertorelli L, Feletti F, Adinolfi D, Tancioni F, Baena R. Antioxidant status and alpha1-antiproteinase activity in subarachnoid hemorrhage patients. Life Sci 63. 821-826, 1998.
52. Mathiesen T, Lefvert AK. Cerebrospinal fluid and blood lymphocyte subpopulations following subarachnoid haemorrhage. Br J Neurosurg 10. 89-92, 1996.
53. Mayhan WG. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276. C1148-C1153, 1999.
54. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51.1128-1134, 2002.
55. Mokri B. The Monro-Kellie hypothesis. applications in CSF volume depletion. Neurology 56. 1746-1748, 2001.
56. Murad A, Ghostine S, Colohan AR. Controlled lumbar drainage in medically refractory increased intracranial pressure. A safe and effective treatment. Acta Neurochir Suppl 102. 89-91, 2008.
57. Nornes H. The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm. J Neurosurg 39. 226-234, 1973.
58. Nornes H. Cerebral arterial flow dynamics during aneurysm haemorrhage. Acta Neurochir (Wien.) 41. 39-48, 1978.
59. Oruckaptan HH, Caner HH, Kilinc K, Ozgen T. No apparent role for neutrophils and neutrophil-derived myeloperoxidase in experimental subarachnoid haemorrhage and vasospasm. A preliminary study. Acta Neurochir (Wien.) 142. 83-90, 2000.
60. Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 25. 554-571, 2005.
61. Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28.399-414, 2006.
62. Park S, Yamaguchi M, Zhou C, Calvert JW, Tang J, Zhang JH. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 35. 2412-2417, 2004.
63. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British aneurysm nimodipine trial. BMJ 298. 636-642, 1989.
64. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain. J Neurosurg 102. 1046-1054, 2005.
65. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36. 992-997, 2005.
66. Rosenberg GA. Matrix metalloproteinases in brain injury. J Neurotrauma 12. 833-842, 1995.
67. Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus 22. E4, 2007.
68. Satoh M, Date I, Ohmoto T, Perkins E, Parent AD. The expression and activation of matrix metalloproteinase-1 after subarachnoid haemorrhage in rats. Acta Neurochir (Wien)147. 187-192, 2005.
69. Schievink WI. Intracranial aneurysms. N Engl J Med 336. 28-40, 1997.
70. Schmidt JM, Rincon F, Fernandez A, Resor C, Kowalski RG, Claassen J, Connolly ES, Fitzsimmons BF, Mayer SA. Cerebral infarction associated with acute subarachnoid hemorrhage. Neurocrit Care 7. 10-17, 2007.
71. Scozzafava J, Brindley PG, Mehta V, Findlay JM. Decompressive bifrontal craniectomy for malignant intracranial pressure following anterior communicating artery aneurysm rupture. Two case reports. Neurocrit Care 6. 49-53, 2007.
72. Sehba FA, Mostafa G, Knopman J, Friedrich V, Jr, Bederson JB. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 101. 633-640, 2004.
73. Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervos-Navarro J. Cerebral edema following experimental subarachnoid hemorrhage. Stroke 13. 368-379, 1982.
74. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types. Results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28. 491-499, 1997.
75. Sugawara T, Jadhav V, Ayer R, Chen W, Suzuki H, Zhang JH. Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats. Stroke 40. 1530-1532, 2009.
76. Thal SC, Sporer S, Klopotowski M, Thal SE, Woitzik J, Schmid-Elsaesser R, Plesnila N, Zausinger S. Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats. J Neurosurg 2009. (doi. 10.3171/2009.3.JNS08412).
77. Trabold B, Rothoerl R, Wittmann S, Woertgen C, Frohlich D. Cerebrospinal fluid and neutrophil respiratory burst after subarachnoid hemorrhage. Neuroimmunomodulation 12. 152-156, 2005.
78. Tuettenberg J, Czabanka M, Horn P, Woitzik J, Barth M, Thome C, Vajkoczy P, Schmiedek P, Muench E. Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure. J Neurosurg 110. 1200-1208, 2009.
79. Turner CP, Panter SS, Sharp FR. Anti-oxidants prevent focal rat brain injury as assessed by induction of heat shock proteins (HSP70, HO-1/HSP32, HSP47) following subarachnoid injections of lysed blood. Brain Res Mol Brain Res 65. 87-102, 1999.
80. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P. Clazosentan (AXV-034343), a selective endothelin Areceptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage. results of a randomized, double-blind, placebocontrolled, multicenter phase IIa study. J Neurosurg 103. 9-17, 2005.
81. Vassilouthis J, Richardson AE. Ventricular dilatation and communicating hydrocephalus following spontaneous subarachnoid hemorrhage. J Neurosurg 51. 341-351, 1979.
82. Voldby B, Enevoldsen EM. Intracranial pressure changes following aneurysm rupture. Part 1. Clinical and angiographic correlations. J Neurosurg 56. 186-196, 1982.
83. Yatsushige H, Ostrowski RP, Tsubokawa T, Colohan A, Zhang JH. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. J Neurosci Res 85. 1436-1448, 2007
84. Zhang Z, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 12. 62-66, 2002.
85. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106. 829-838, 2000.